539730 — Fredun Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.32bn
- IN₹4.58bn
- IN₹3.47bn
- 33
- 40
- 36
- 27
Annual cashflow statement for Fredun Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 23.5 | 20.1 | 63.1 | 108 | 156 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -4.1 | 20.5 | 32 | 39 | 185 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -146 | -63.3 | -141 | -343 | -387 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -106 | 1.7 | -23.8 | -144 | -4.39 |
| Capital Expenditures | -14.9 | -13.9 | -42.7 | -94.9 | -76.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | 1.43 | 0.901 | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.9 | -13.9 | -41.3 | -94 | -76.4 |
| Financing Cash Flow Items | -44.5 | -54.6 | -56.6 | -88.9 | -130 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 137 | -7.13 | 74.7 | 252 | 59.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.9 | -19.3 | 9.57 | 13.6 | -20.8 |